PRL (phospho S163) polyclonal antibody
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
-
Specification
Product Description
Rabbit polyclonal antibody raised against synthetic phosphopeptide of PRL.
Immunogen
Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding S163 of human PRL.
Host
Rabbit
Reactivity
Human
Form
Liquid
Purification
Protein A purification
Recommend Usage
ELISA (1:1000)
Dot Blot (1:500)
The optimal working dilution should be determined by the end user.Storage Buffer
In PBS (0.09% sodium azide)
Storage Instruction
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.Note
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Applications
Immunohistochemistry
Enzyme-linked Immunoabsorbent Assay
Dot Blot (Peptide)
Dot blot analysis of PRL (phospho S163) polyclonal antibody (Cat # PAB8179) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5 ug/mL. -
Gene Info — PRL
Entrez GeneID
5617Protein Accession#
P01236;NP_000939Gene Name
PRL
Gene Alias
-
Gene Description
prolactin
Omim ID
176760Gene Ontology
HyperlinkOther Designations
OTTHUMP00000017727
-
Interactome
-
Pathway
-
Disease
-
Publication Reference
-
Prolactin does not require insulin-like growth factor intermediates but synergizes with insulin-like growth factor I in human breast cancer cells.
Carver KC, Schuler LA.
Molecular Cancer Research: MCR 2008 Apr; 6(4):634.
-
Plasma levels of Th1/Th2 type cytokine are associated with change of prolactin and GH/IGF-I in hemodialysis patients.
Liu ML, Xu G, Xue SR, Zhong XC, Chen GX, Chen ZJ.
The International Journal of Artificial Organs 2008 Apr; 31(4):303.
-
Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2.
Swaminathan G, Varghese B, Thangavel C, Carbone CJ, Plotnikov A, Kumar KG, Jablonski EM, Clevenger CV, Goffin V, Deng L, Frank SJ, Fuchs SY.
The Journal of Endocrinology 2008 Feb; 196(2):R1.
-
Prolactin does not require insulin-like growth factor intermediates but synergizes with insulin-like growth factor I in human breast cancer cells.
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com